Patents Examined by Jean F Vollano
  • Patent number: 6717007
    Abstract: An improved regiospecific synthesis of organic phosphonous acids, comprising of hydrophosphorylation of an olefin with hydrophosphorous acid in the presence of an inorganic persulfate, which acts as a source of free radicals at a pH ranging from 4.5 to 7.0, in which the orientation of addition is anti-Markonikoff. The process enables production of organic phosphonous acids at lower temperature and atmospheric pressure under milder pH conditions for better regioselectivity in hydrophosphorylation and obtain the phosphonous acid with good yield and purity following simple isolation procedure. Phosphonous acids obtained by the process are commercially valuable as effective detergents and wetting agents, lubricants and lubricant additives, plasticizers for plastics and resins, corrosion inhibitors, chemicals including insecticides and pesticides, cobalt extractants and as key intermediates for preparation of commercially important angiotensin converting enzyme (ACE) inhibitors.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: April 6, 2004
    Assignee: Lupin Limited
    Inventors: Sushil Kumar Dubey, Venkat Rajgopal, Anil Vir Singh, Saswata Lahiri, Mukesh Jagannath Wani
  • Patent number: 6717011
    Abstract: The application relates to diazaphospholidine compounds of Formula 1 and Formula 2: where: A and B are independently selected from C(R22R23) and C(R22R23)C(R24R25); R1, R2, R3, R4, R18, R19, R20, R21, R22, R23, R24 and R25 each may not be present and each may be independently selected from H, halide —OH, —SO2R26 (where R26 is selected from a group as defined for R22, R23, R24 and R25), —SH, —NO2, —NH2, ═O, ═S, straight chain, branched chain, cyclic, saturated, non-saturated, substituted or non-substituted alkyl, hydroalkyl, carboalkyl, alkoxy, amino, alkenyl, aryl and —CH2 Ar (where Ar is aryl or substituted aryl), preferably containing 1 to 6 carbons, or a silane containing 1 to 6 silicon atoms, wherein, where an R1, R2, R3, R4, R18, R19, R20, R21, R22, R23, R24 and/or R25 group is not present an unsaturated bond is formed; R5 and R17 are selected from H, —NH2, —OH, halide or a substituted or non-substituted strai
    Type: Grant
    Filed: December 12, 2001
    Date of Patent: April 6, 2004
    Assignee: Stylacats Limited
    Inventors: Martin Wills, Simon William Breeden
  • Patent number: 6713044
    Abstract: The present invention is directed to labeled compounds, [2H1, 13C], [2H2, 13C] and [2H3, 13C]methyl aryl sulfides wherein the 13C methyl group attached to the sulfur of the sulfide includes exactly one, two or three deuterium atoms and the aryl group is selected from the group consisting of 1-naphthyl, substituted 1-naphthyl, 2-naphthyl, substituted 2-naphthyl, and phenyl groups with the structure wherein R1, R2, R3, R4, and R5 are each independently, hydrogen, a C1-C4 lower alkyl, a halogen, an amino group from the group consisting of NH2, NHR and NRR′ where R and R′ are each a C1-C4 lower alkyl, a phenyl, or an alkoxy group. The present invention is also directed to processes of preparing [2H1, 13C], [2H2,13C] and [2H3, 13C]methyl aryl sulfides wherein the 13C methyl group attached to the sulfur of the sulfide includes exactly one, two or three deuterium atoms.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: March 30, 2004
    Assignee: The Regents of the University of California
    Inventors: Rodolfo A. Martinez, Marc A. Alvarez, Louis A. Silks, III, Clifford J. Unkefer
  • Patent number: 6709645
    Abstract: The present invention is directed to labeled compounds, for example, isotopically enriched mustard gas metabolites including: [1,1′,2,2′-13C4]ethane, 1,1′-sulfonylbis[2-(methylthio); [1,1′,2,2′-13C4]ethane, 1-[[2-(methylsulfinyl)ethyl]sulfonyl]-2-(methylthio); [1,1′,2,2′-13C4]ethane, 1,1′-sulfonylbis[2-(methylsulfinyl)]; and, 2,2′-sulfinylbis([1,2-13C2]ethanol of the general formula where Q1 is selected from the group consisting of sulfide (—S—), sulfone (—S(O)—), sulfoxide (—S(O2)—) and oxide (—O—), at least one C* is 13C, X is selected from the group consisting of hydrogen and deuterium, and Z is selected from the group consisting of hydroxide (—OH), and —Q2—R where Q2 is selected from the group consisting of sulfide (—S—), sulfone(—S(O)—), sulfoxide (—S(O2)—) an
    Type: Grant
    Filed: April 18, 2003
    Date of Patent: March 23, 2004
    Assignee: The Regents of the University of California
    Inventors: Rodolfo A. Martinez, Louis A. Silks, III, Clifford J. Unkefer, Robert Atcher
  • Patent number: 6706926
    Abstract: A non-symmetrical diphosphine of the formula R1R2P—(Z)—PR3R4 wherein Z represents a chain of 2 to 4 carbon atoms which may be substituted, which chain may be saturated or unsaturated, and R1, R2, R3 and R4, which may be the same or differ, are aliphatic, aromatic or heteroaromatic groups attached to the phosphorus by carbon, nitrogen, oxygen or sulphur such that each phosphorus atom and its substituents independently form a single enantiomer.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: March 16, 2004
    Assignee: Isis Innovation Limited
    Inventors: John Michael Brown, Duncan Carmichael, Henry Doucet
  • Patent number: 6706914
    Abstract: A method for generating a concentrated solution of rhodium starting from solid RHI3 and other solid rhodium sources by combination with a reducing agent, preferably hydrazine and hydrazine derivatives. The solution does not form any precipitate of rhodium iodide or other compounds even upon admixture with large quantities of hydriodic acid. The solution is stable at ambient conditions, very stable towards air and is easily prepared without application of external pressure and heating sources.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: March 16, 2004
    Assignee: Haldor Topsoe A/S
    Inventor: Niels Christian Schiødt
  • Patent number: 6699909
    Abstract: The present invention relates to therapeutically active novel aminoindanes of formula (I). Also provided is a method of preparing compounds of formula (I), and pharmaceutical compositions comprising the compounds. The novel compounds act as modulators of metabotropic glutamate receptors and, as such, are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: March 2, 2004
    Assignee: Prescient NeuroPharma Inc.
    Inventor: Kenneth Curry
  • Patent number: 6700019
    Abstract: The invention concerns a novel method for preparing tetrakis(pentafluorophenyl)borate derivatives of general formula MB(C6F5)4, M being selected among Na+, Li+, or K+, wherein: (a) a C6F5X solution, X being selected among H, Cl, Br or I, in anhydrous butylic ether is contacted with an alkyllithium, the mol ratio of C6F5X/alkyllithium being 1 to 1.1, and the alkyl radical, linear or branched comprising 1 to 10 carbon atoms; (b) the resulting product is contacted with previously non-dissolved BR3, R, identical or different being selected among a chlorine atom, a fluorine atom, a bromine atom, an alkoxy radical comprising between 1 and 4 carbon atoms.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: March 2, 2004
    Assignee: Rhodia Chimie
    Inventors: Michel Dury, Christian Priou, Jacques Richard
  • Patent number: 6696613
    Abstract: A process for preparing compounds of the formula: wherein R2 is lower alkyl; or phenyl optionally substituted by from one to five groups, the same or different, which are lower alkyl, lower haloalkyl, halogen or —SR4; R3 is halogen, lower alkyl, lower haloalkyl, lower alkoxy, lower haloalkoxy, —S-alkyl, cycloalkyl having from 3 to 7 carbon atoms in the ring, alkenyl or alkynyl having from 3 to 7 carbon atoms, or —(CR5R6)—SR2 wherein q is one or two; R4 is lower alkyl; R5 and R6 independently represent hydrogen, lower alkyl or lower haloalkyl; and n is zero or an integer from one to three; intermediate compounds of the formula: and processes for preparing them.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: February 24, 2004
    Assignee: Rhone Poulenc Agrochimie
    Inventors: Virginie Pevere, Alain Gadras, Susan Mary Cramp, Charles Walter Ellwood
  • Patent number: 6696589
    Abstract: The present invention provides a novel process for the removal and recovery of radionuclides from waste waters and process streams. The process of the present invention utilizes a combination of a supported liquid membrane (SLM) and a strip dispersion to improve extraction of the target species while increasing membrane stability and reducing processing costs. Additionally, the invention provides a family of new extractants, alkyl phenylphosphonic acids, for the removal and recovery of radionuclides and/or metals, including the use of the new extractants in the process. The new extractant selectively removes radionuclides and metals from the feed stream to provide a concentrated strip solution of the target species.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: February 24, 2004
    Assignee: Commodore Separation Technologies, Inc.
    Inventor: W. S. Winston Ho
  • Patent number: 6696601
    Abstract: New hydrate forms of alendronate sodium, having water content of between about one and about twelve percent, and processes for their manufacture, are disclosed. New crystalline forms of alendronate sodium B, D, E, F, G and H, and processes for manufacturing them, are also disclosed. These new forms of alendronate sodium are suitable for incorporation into pharmaceutical compositions for combating bone resorption in bone diseases.
    Type: Grant
    Filed: July 3, 2001
    Date of Patent: February 24, 2004
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Nina Finkelstein, Ramy Lidor-Hadas, Judith Aronhime
  • Patent number: 6693212
    Abstract: The invention relates to tris-(oxalato)phosphates of the general formula M[P(C2O4)3] wherein M=H, a metal or N(R1R2R3R4), where R1, R2, R3, R4, are independently H or an alkyl group comprising 1 to 8 C atoms. The invention also relates to a method for preparing such compounds as well as to their use.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: February 17, 2004
    Assignee: Chematall GmbH
    Inventors: Ulrich Wietelmann, Klaus Schade, Uwe Lischka
  • Patent number: 6693210
    Abstract: Provided are a novel triphenyl phosphine derivative synthesized from a triphenylphosphine and a hydroxy-containing lactone; a palladium and a nickel complexes comprising the derivative as a ligand; and a process for preparing a biaryl derivative using the complex as a catalyst. A product can be easily separated from a catalyst or a phosphorus compound, and biaryl derivative can be synthesized in a higher yield, by using the complex of the present invention as a catalyst.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: February 17, 2004
    Assignee: Mitsubishi Rayon Co., Ltd.
    Inventor: Norio Miyaura
  • Patent number: 6693224
    Abstract: The invention relates to a method for the production of 1,2-dichloroethane by direct chlorination using chlorine and ethene in which, despite low reaction temperatures during direct chlorination, reaction heat produced is nevertheless used. According to the invention, vaporous 1,2-dichloroethane obtained in the direct chlorination reactor is compressed and the compressed 1,2-dichloroethane is transported to heat exchangers whereby heat is given off by the 1,2-dichloroethane. The invention also relates to a device including a turbocompressor arranged directly after the direct chlorination reactor.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: February 17, 2004
    Assignee: Uhde GmbH
    Inventor: Joachim Motz
  • Patent number: 6689915
    Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: February 10, 2004
    Assignee: Warner-Lambert Company LLC
    Inventors: Garrett Stewart Hoge, II, Om Prakash Goel
  • Patent number: 6686397
    Abstract: Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed: Compositions comprising the same, methods of preparation and methods for the prophylaxis or treatment of obesity are also disclosed herein.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: February 3, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Patent number: 6686506
    Abstract: The invention relates to a process for the preparation of organic disulfides by oxidation of mercaptans with sulfur dissolved in an organic disulfide using an amine as catalyst, where the mercaptans are used as “crude mercaptan stream” from a reaction of alcohols with hydrogen sulfide over a catalyst suitable for mercaptan synthesis. Furthermore, the invention relates to the use of the organic disulfides for the preparation of alkanesulfonic acids.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: February 3, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Werner Hesse, Hans-Josef Sterzel, Christian Tragut
  • Patent number: 6683219
    Abstract: The present invention provides a method for the synthesis of an A-ring synthon phosphine oxide used in the preparation of 19-nor vitamin D compounds, and to novel synthetic intermediates formed during the synthesis. The new method prepares the phosphine oxide from (D)-glucose.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: January 27, 2004
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Masato Shimizu, Sachiko Yamada
  • Patent number: 6683218
    Abstract: A fluoroaryl magnesium derivative expressed by General Formula (1): where each of R1-R5 represents a hydrogen atom, a fluorine atom, a hydrocarbon group, or an alkoxy group while at least one of R1-R5 representing a fluorine atom, and Xa represents a chlorine atom, a bromine atom, or an iodine atom; and boron halide expressed by General Formula (2): BXb3  (2)  where Xb represents a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom, are reacted with each other in a solvent (a) containing diethyl ether and/or tetrahydrofuran, after which the resulting reaction solution is added to a solvent (b) having a higher boiling point than diethyl ether and/or tetrahydrofuran while diethyl ether and/or tetrahydrofuran are distilled out.
    Type: Grant
    Filed: October 21, 1997
    Date of Patent: January 27, 2004
    Assignee: Nippon Shokubai Co., Ltd.
    Inventors: Hitoshi Mitsui, Ikuyo Katsumi, Naoko Yamamoto
  • Patent number: 6683208
    Abstract: New optically active bis[1-phospha-2,3-diphenyl-4,5-dimethylnorbornadiene] diphosphines and new optically active transition metal complexes with said phosphines are described. The complexes are useful as catalysts to promote hydrogenation of substrates.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: January 27, 2004
    Assignee: Rhone-Poulenc Chimie
    Inventors: Francois Mathey, Frédéric Robin, Francois Mercier, Michel Spagnol